Evans syndrome complicating fludarabine treatment for advanced B-CLL.
Shvidel
L
L
Shtarlid
M
M
Klepfish
A
A
Sigler
E
E
Berrebi
A
A
D000743:Anemia, Hemolytic / Q000139:chemically induced*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013577:Syndrome; D013921:Thrombocytopenia / Q000139:chemically induced*; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine